183 online
 
Most Popular Choices
Share on Facebook 69 Printer Friendly Page More Sharing Summarizing
Sci Tech    H3'ed 12/3/16

Teens Recreate Martin Shkreli's Pricey Pill for Pennies

Quicklink Submitted By   1 comment, In Series: Karma
Author 1820
Managing Editor

Meryl Ann Butler
Follow Me on Twitter     Message Meryl Ann Butler
Become a Fan
  (82 fans)

A group of Australian high schoolers have cheaply created the active ingredient in the drug Daraprim, which “Pharma Bro” Martin Shkreli hiked the cost of by 5,500 percent. Shkreli raised the cost of Daraprim from $13.50 to $750.00 last year as then-CEO of Turing Pharmaceuticals, which earned him nearly universal condemnation and a congressional subpoena. The students produced about $110,000 worth of the active ingredient in Daraprim--which has passed testing for purity-- using ingredients that cost $20.

Read the rest of the story HERE:

At www.alternet.org
News 2   Valuable 2   Well Said 1  
Rate It | View Ratings

Meryl Ann Butler Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

Meryl Ann Butler is an artist, author, educator and OpedNews Managing Editor who has been actively engaged in utilizing the arts as stepping-stones toward joy-filled wellbeing since she was a hippie. She began writing for OpEdNews in Feb, 2004. She became a Senior Editor in August 2012 and Managing Editor in January, (more...)
 

Related Topic(s): Martin Shkreli; Students; Teenagers, Add Tags
Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Follow Me on Twitter     Writers Guidelines

 
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEd News Newsletter
Name
Email
   (Opens new browser window)
 

To View Comments or Join the Conversation:

Tell A Friend